16 related articles for article (PubMed ID: 38594692)
1. MCM10 as a novel prognostic biomarker and its relevance to immune infiltration in gliomas.
Tian QS; Zhang Q; Huang W
Technol Health Care; 2023; 31(4):1301-1317. PubMed ID: 36872806
[TBL] [Abstract][Full Text] [Related]
2. SYK inhibition blocks proliferation and migration of glioma cells and modifies the tumor microenvironment.
Moncayo G; Grzmil M; Smirnova T; Zmarz P; Huber RM; Hynx D; Kohler H; Wang Y; Hotz HR; Hynes NE; Keller G; Frank S; Merlo A; Hemmings BA
Neuro Oncol; 2018 Apr; 20(5):621-631. PubMed ID: 29401256
[TBL] [Abstract][Full Text] [Related]
3. Chitinase-3 like-protein-1 promotes glioma progression via the NF-κB signaling pathway and tumor microenvironment reprogramming.
Zhao T; Zeng J; Xu Y; Su Z; Chong Y; Ling T; Xu H; Shi H; Zhu M; Mo Q; Huang X; Li Y; Zhang X; Ni H; You Q
Theranostics; 2022; 12(16):6989-7008. PubMed ID: 36276655
[No Abstract] [Full Text] [Related]
4. Siglec15 is a prognostic indicator and a potential tumor-related macrophage regulator that is involved in the suppressive immunomicroenvironment in gliomas.
Wang J; Xu L; Ding Q; Li X; Wang K; Xu S; Liu B
Front Immunol; 2023; 14():1065062. PubMed ID: 37325664
[TBL] [Abstract][Full Text] [Related]
5. GPR37 expression as a prognostic marker in gliomas: a bioinformatics-based analysis.
Liang K; Guo Z; Zhang S; Chen D; Zou R; Weng Y; Peng C; Xu Z; Zhang J; Liu X; Pang X; Ji Y; Liao D; Lai M; Peng H; Ke Y; Wang Z; Wang Y
Aging (Albany NY); 2023 Oct; 15(19):10146-10167. PubMed ID: 37837549
[TBL] [Abstract][Full Text] [Related]
6. SIRPB1 regulates inflammatory factor expression in the glioma microenvironment via SYK: functional and bioinformatics insights.
Geng R; Zhao Y; Xu W; Ma X; Jiang Y; Han X; Zhao L; Li Y
J Transl Med; 2024 Apr; 22(1):338. PubMed ID: 38594692
[TBL] [Abstract][Full Text] [Related]
7. Immune microenvironment of gliomas.
Gieryng A; Pszczolkowska D; Walentynowicz KA; Rajan WD; Kaminska B
Lab Invest; 2017 May; 97(5):498-518. PubMed ID: 28287634
[TBL] [Abstract][Full Text] [Related]
8.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
9.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]